Defending Content Spend 101: Make Sure You Involve the Right People
Information managers defending content spend need to make sure they talk to the right people and target the message for their needs.
Accelerating Drug R&D While Minimizing Costs
If drug research teams want to accelerate their R&D efforts they need to start demonstrating value in their content. Here’s how…
Rise of the Researchers at London Book Fair 2017
CCC CEO Tracey Armstrong led a panel discussion on how researchers are driving innovation in scientific publishing at London Book Fair.
How (and Why) You Should Establish Your Content Collection as a Portfolio
If you’ve been subscribing to an ad hoc content purchasing process, consider the benefits of creating a content portfolio to better understand the content investment.
3 Ways Big Data Affects Biomedical Research
With the help of big data, biomedical research can now access span swaths of medical records and test results to make smarter, swifter decisions.
Can Copyright Undermine Fake News?
Platforms seek tech-driven solutions to combat fake news, but copyright enforcement may be the simplest solution.
Understanding the Direct Impact of R&D Content Investments
It’s not until information managers draw attention to the importance of third party content and its value that they can start to validate its costs.
Finding a Cure for Cancer: Open Data, Open Collaboration and Open Minds
Every step towards creating a medical environment with access to anonymized open data is a step in the right direction.
Enterprise Content Management: Helping you declutter your content
Smart content management tools help you take a digital-first approach to your business.
Top Copyright Questions for Marketers
Can I use content if I’m not profiting from it? How do Creative Commons and Digital Millennium Copyright Act (DMCA) fit into this?